Manage Account - Modern Medicine
Drug Shows Long-Term Efficacy for Psoriasis
Ustekinumab improves psoriasis area and severity

Treatment of patients with moderate-to-severe psoriasis with ustekinumab leads to long-term improvement in psoriasis area and severity compared with placebo, according to a report in the May 17 issue of The Lancet.

The journal page you requested is now available only to registered Modern Medicine members.

Register Here

Registration is Free!
(and Takes Less than a Minute)

RegisterUS Physicians, click here
for express registration.

RegisterHealthcare Professionals,
click here

Modern Medicine Offers:
» Practice Management Advice
» CME / ICD-9 Coding / Formulary
» Patient Education Handouts
» Peer-reviewed Articles
» Conference Coverage, Email Alerts & More

Click Here to Watch the Tour

Already Registered?

Login Now

Login Email:Password:
Forgot Your Password?Remember me.

Click here